S100A8 and Chronic Eosinophilic Leukemia, Not Otherwise Specified: Collectively, our in vivo findings demonstrate that S100A8 and S100A9 practically regulate the apoptotic mechanisms of eosinophilic abnormalities such as CEL and HES.